The PNPLA3 gene and Variants of the TM6SF2 gene encode a protein involved in lipid metabolism and are associated with an increased risk of developing NAFLD and its progression to more severe forms of liver disease, such as MASH and cirrhosis [28]. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.